| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: ENCX |
| Security Type |
Common Stock |
| Lead Underwriter |
First Albany Capital Inc |
| Days In Registration |
119 |
| Date Filed |
27-Feb-2007 |
| Form Filed | F-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Manufacture prescription pharmaceuticals intended for final consumption, including biotech products and antibiotics |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
18.25M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
5.75M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
862.5K |
| File Amount |
- |
| File Price Range |
$13.00 - $11.00 |
| File Mid Price |
$12.00 |
|
